Published in Cancer Weekly, October 25th, 1999
E.S. Stavridi and colleagues from the Wistar Institute, Pennsylvania, studied protein interactions that interfere with p53-based cancer gene therapies. Their results were presented in a recent issue of Protein Science ("Change in Oligomerization Specificity of the p53 Tetramerization Domain by Hydrophobic Amino Acid Substitutions," Protein Science, September 1999;8(9):1773-1779).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.